{"paper_id":"efff39db-3634-4f34-a4f6-6a78be94a091","body_text":"Abstract\nChronic pelvic pain (CPP) is a common disorder in clinical practice. Patients who suffer from it often have their daily life being disturbed by the pain for a long time before they visit doctors as CPP is defined as cyclical or noncyclical pain lasting for over 6 months. Patients with CPP may present with dysmenorrhea, dyspareunia, dyspareunia, and dyspareunia. Up to 24% of women worldwide suffer from CPP [1]. Clinically, many patients often fail to detect clear pathological changes through various diagnostic tests, and painful symptoms are the primary presentation at the clinic. Causes of CPP include gastrointestinal, urological, gynecological, oncological, musculoskeletal, and psychosocial factors [2]. When evaluating and treating patients, subspecialists are often inadequate in multidisciplinary training and knowledge of the various causes required. As a result, patients may have seen multiple physicians, undergone multiple tests and examinations, and may have undergone surgical procedures before seeking treatments, yet without significant improvement in associated symptoms. With further research on CPP suggesting that CPP may be just a chronic symptom without any pathological changes and that pain is closely related to sexual function, defecation, and urination due to its location and is often accompanied by emotional and psychological changes in the patient, more medical practitioners have now become interested in the diagnosis and treatment of patients with CPP. This chapter attempts to provide a multidisciplinary overview of CPP with an evaluation focus, including its etiology, epidemiology, diagnosis, and treatment of common CPP syndromes.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nLatthe P, Latthe M, Say L, Gülmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6:177.\nEvidence-based management of chronic pelvic pain. Reiter RC. Clin Obstet Gynecol. 1998;41:422–35.\nMarszalek M, Wehrberger C, Temml C, Ponholzer A, Berger I, Madersbacher S. Chronic pelvic pain and lower urinary tract symptoms in both sexes: analysis of 2749 participants of an urban health screening project. Eur Urol. 2009;55(2):499–507.\nMuhammad YY, Nossier SA, El-Dawaiaty AA. Prevalence and characteristics of chronic pelvic pain among women in Alexandria. Egypt J Egypt Public Health Assoc. 2011;86(1–2):33–8.\nGarcia-Perez H, Harlow SD, Erdmann CA, Denman C. Pelvic pain and associated characteristics among women in northern Mexico. Int Perspect Sex Reprod Health. 2010;36(2):90–8.\nGrace VM, Zondervan KR. Chronic pelvic pain in New Zealand: prevalence, pain severity, diagnoses and use of the health services. Aust Nz J Public Health. 2004;28(4):369–75.\nMathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, healthrelated quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.\nAbbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68–81.\nDrossman DA. The functional gastrointestinal disorders and the Rome II process. Gut. 1999;45(Suppl 2):II1–5.\nCurry A, Williams T, Penny ML. Pelvic inflammatory disease: diagnosis, management, and prevention. Am Fam Physician. 2019;100:357–64. https://www.aafp.org/pubs/afp/issues/2019/0915/p357.html.\nSimms I, Stephenson JM, Mallinson H, et al. Risk factors associated with pelvic inflammatory disease. Sex Transm Infect. 2006;82:452–7.\nWorkowski KA. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015;61(Suppl 8):S759–62.\nZheng Y, Jin Y, Zhu HB, Xu ST, Xia YX, Huang Y. The anti-inflammatory and anti-nociceptive activities of Patrinia villosa and its mechanism on the proinflammatory cytokines of rats with pelvic inflammation. Afr J Tradit Complement Altern Med. 2012;9(3):295–302. https://doi.org/10.4314/ajtcam.v9i3.\nJuganavar A, Joshi KS. Chronic pelvic pain: a comprehensive review. Cureus. 2022;14(10):e30691. https://doi.org/10.7759/cureus.30691.\nNisenblat V, Bossuyt PM, Shaikh R, et al. Blood biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;2016(5):CD012179.\nArafah M, Rashid S, Akhtar M. Endometriosis: a comprehensive review. Adv Anat Pathol. 2021;28:30–43.\nSaunders PT, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184:2807–24.\nMechsner S. Endometriosis: an often unrecognized pain disorder (article in German). Schmerz. 2016;30:477–90.\nSenapati S, Atashroo D, Carey E, Dassel M, Tu MF. Surgical interventions for chronic pelvic pain. Curr Opin Obstet Gynecol. 2016;28:290–6.\nDueholm M, Lundorf E, Hansen ES, Sørensen JS, Ledertoug S, Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril. 2001;76:588–94.\nBaradwan S, Baradwan A, Baradwan A, Al-Jaroudi D. Hydrosalpinx with acute abdominal pain during the third trimester of pregnancy: a case report. Case Rep Womens Health. 2018;20:e00077.\nLiddle AD, Davies AH. Pelvic congestion syndrome: chronic pelvic pain caused by ovarian and internal iliac varices. Phlebology. 2007;22:100–4.\nTu FF, Hahn D, Steege JF. Pelvic congestion syndrome-associated pelvic pain: a systematic review of diagnosis and management. Obstet Gynecol Surv. 2010;65:332–40.\nYongjun Z, Tingjie Z, Xiaoqiu Y, Zhiying F, Feng Q, Guangke X, Jinfeng L, Fachuan N, Xiaohong J, Yanqing L. A survey of chronic pain in China. Libyan J Med. 2020;15(1):1730550. https://doi.org/10.1080/19932820.2020.1730550.\nPeters AA, van Dorst E, et al. A randomized clinical trial to compare two different approaches in women with chronic pelvic pain. Obstet Gynecol. 1991;77:740–4.\nLi Hui LY, Jie Z. Laparoscopic diagnosis and therapy for chronic pelvic pain. China J Endosc. 2004:04.\nCheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain. Cochrane Database Syst Rev. 2014;3:CD008797.\nCottrell AM, Schneider MP, Goonewardene S, Yuan Y, Baranowski AP, Engeler DS, Borovicka J, Dinis-Oliveira P, Elneil S, Hughes J, Messelink BJ, de C Williams AC. Benefits and harms of electrical neuromodulation for chronic pelvic pain: a systematic review. Eur Urol Focus. 2020;6(3):559–71.\nSator-Katzenschlager SM, Scharbert G, Kress HG, Frickey N, Ellend A, Gleiss A, Kozek-Langenecker SA. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr. 2005;117(21–22):761–8.\nAllen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2009;2:CD004753.\nLewis SC, Bhattacharya S, Wu O, Vincent K, Jack SA, Critchley HO, Porter MA, Cranley D, Wilson JA, Horne AW. Gabapentin for the Management of Chronic Pelvic Pain in women (GaPP1): a pilot randomised controlled trial. PLoS One. 2016;11(4):e0153037.\nHaugstad GK, Kirste U, Leganger S, Haakonsen E, Haugstad TS. Somatocognitive therapy in the management of chronic gynaecological pain. A review of the historical background and results of a current approach. Scand. J Pain. 2018;2(3):124–9.\nHaugstad GK, Haugstad TS, Kirste UM, Leganger S, Wojniusz S, Klemmetsen I, Malt UF. Continuing improvement of chronic pelvic pain in women after short-term Mensendieck somatocognitive therapy: results of a 1-year follow-up study. Am J Obstet Gynecol. 2008;199(6):615.e1–8.\nLouw A, Zimney K, O'Hotto C, Hilton S. The clinical application of teaching people about pain. Physiother Theory Pract. 2016;32(5):385–95.\nHarada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial. Fertil Steril. 2008;90(5):1583–8.\nMoldofsky H, Harris HW, Archambault WT, Kwong T, Lederman S. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study. J Rheumatol. 2011;38(12):2653–63.\nAbbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type a for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006;108(4):915–23.\nMontenegro ML, Braz CA, Rosa-e-Silva JC, Candido-dos-Reis FJ, Nogueira AA, Poli-Neto OB. Anaesthetic injection versus ischemic compression for the pain relief of abdominal wall trigger points in women with chronic pelvic pain. BMC Anesthesiol. 2015;15:175.\nRoyal college of Obstetricians and Gynaecologists, 2015. The initial management of chonic pelvic pain, May 2012. https://www.rcog.org.uk/media/muab2gj2/gtg_41.pdf.\nHoward FM. An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies. J Am Assoc Gynecol Laparosc. 2000;7(4):477–88. https://doi.org/10.1016/s1074-3804(05)60360-x.\nAuthor information\nAuthors and Affiliations\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.\nAbout this chapter\nCite this chapter\nJiang, H. (2024). Chronic Abdominal Pain Due to Obstetric and Gynecological Factors. In: Xia, M., Fan, B., Jiang, H. (eds) Visceral Pain. Springer, Singapore. https://doi.org/10.1007/978-981-99-9167-9_12\nDownload citation\nDOI: https://doi.org/10.1007/978-981-99-9167-9_12\nPublished:\nPublisher Name: Springer, Singapore\nPrint ISBN: 978-981-99-9166-2\nOnline ISBN: 978-981-99-9167-9\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}